NASDAQ:IKT | Income Statement | Inhibikase Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$0.00$13.39M$7.66M-$21.05M$0.00-$19.59M-$0.11-$0.11174,571,543174,571,543
2026-03-31$0.00$10.84M$7.38M-$17.84M$0.00-$16.38M-$0.10-$0.10172,306,932172,306,932
2025-12-31$6.36M$6.77M-$13.78M$0.00-$12.73M-$0.09-$0.098,442,3858,442,385
2025-09-30$0.00$7.65M$5.61M-$12.77M$0.00-$11.93M-$0.13-$0.1390,050,97390,050,973
2025-06-30$0.00$5.27M$5.92M-$10.83M$0.00-$9.92M-$0.11-$0.1190,009,62590,009,625
2025-03-31$0.00$10.51M$5.25M-$14.6M$0.00-$13.68M-$0.15-$0.1589,537,17189,537,171
2024-12-31$0.00$7.19M$5.74M-$12.93M$0.00-$12.13M$0.87$0.8716,120,11716,120,117
2024-09-30$0.00$4.19M$1.64M-$5.83M$0.00-$5.78M-$0.65-$0.658,882,5708,882,570
2024-06-30$0.00$3.08M$1.97M-$5.05M$0.00-$4.96M-$0.66-$0.667,535,6677,535,667
2024-03-31$0.00$2.75M$2.03M-$4.78M$0.00-$4.65M-$0.73-$0.736,340,6976,340,697
2023-12-31$1.00$3M$1.4M-$4.4M-$4.18M-$0.23-$0.23967,763967,763
2023-09-30$79,569.00$3.23M$1.62M-$4.77M$0.00-$4.6M-$0.86-$0.865,342,3375,342,337
2023-06-30$116,410.00$4.54M$1.78M-$6.2M$0.00-$5.78M-$1.11-$1.115,226,1015,226,101
2023-03-31$64,521.00$2.85M$1.93M-$4.71M$0.00-$4.48M-$0.98-$0.984,585,0134,585,013
2022-12-31$63,566.00$3.05M$1.34M-$4.33M-$4.28M-$1.02-$1.0200
2022-09-30$7,291.00$2.98M$1.54M-$4.51M$0.00-$4.49M-$1.06-$1.064,224,2944,224,294
2022-06-30$6,552.00$2.98M$1.66M-$4.64M$0.00-$4.64M-$1.10-$1.104,224,2944,224,294
2022-03-31$46,031.00$3.02M$1.67M-$4.64M$0.00-$4.64M-$0.18-$0.1825,205,45425,205,454
2021-12-31$1,944.00$3.39M$1.65M-$5.04M-$5.04M-$0.20-$0.202,340,7772,340,777
2021-09-30$328,459.00$3.15M$1.64M-$4.47M-$4.47M-$0.18-$0.1825,143,55925,143,559
2021-06-30$1.36M$2.38M$1.61M-$2.63M-$2.64M-$0.22-$0.2212,241,93512,241,935
2021-03-31$1.41M$2.43M$1.6M-$2.63M$0.00-$2.64M10,053,949
2020-12-31$170,416.00$226,944.00$1.14M-$1.2M-$1.21M25,064
2020-09-30$37,680.00$120,569.00$580,820.00-$663,709.00-$670,599.008,198,754
2020-06-30$219,585.00$263,175.00$370,331.00-$413,921.00-$421,869.008,181,938
2020-03-31$270,787.00$283,114.00$527,688.00-$540,015.00$0.00-$547,440.008,181,734

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$29.79M$23.56M-$51.97M-$48,259.00$0.00-$48.26M-$0.49-$0.4998,310,19098,310,190
2024-12-31$0.00$17.21M$11.38M-$28.59M-$27,520.00$0.00-$27.52M-$1.16-$1.1623,712,22023,712,220
2023-12-31$260,501.00$13.62M$6.73M-$20.09M-$19.03M-$3.16-$3.166,028,2106,028,210
2022-12-31$123,440.00$12.03M$6.22M-$18.13M-$18.05M-$4.28-$4.284,223,0994,223,099
2021-12-31$3.1M$11.36M$6.51M-$14.77M-$14.79M-$0.81-$0.8118,209,19818,209,198
2020-12-31$698,468.00$893,802.00$2.62M-$2.82M-$2.85M8,212,581